Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Practolol peritonitis presenting as a pelvic mass.

B J Trudinger, D H Fitchett

    British Journal of Obstetrics and Gynaecology
    |April 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A comparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary care.

    Diabetes, obesity & metabolism·2013
    Same author

    Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort study.

    International journal of clinical practice·2012
    Same author

    An improved method for measuring plasma glycocalicin in the investigation of causes of thrombocytopaenia.

    Platelets·2010
    Same author

    A modification of the uterine artery restriction technique in the guinea pig fetus produces asymmetrical ultrasound growth.

    Placenta·2009
    Same author

    Misoprostol versus dinoprostone for cervical priming prior to induction of labour in term pregnancy: a randomised controlled trial.

    The Australian & New Zealand journal of obstetrics & gynaecology·2001
    Same author

    Ultrasound measurement of biparietal diameter and umbilical artery blood flow in the normal fetal guinea pig.

    Comparative medicine·2000
    Same journal

    Livial: an economic appraisal.

    British journal of obstetrics and gynaecology·2000
    Same journal

    Livial: a review of clinical studies.

    British journal of obstetrics and gynaecology·2000
    Same journal

    Place of birth and shoulder dystocia.

    British journal of obstetrics and gynaecology·1999
    Same journal

    The value of the negative predictive values.

    British journal of obstetrics and gynaecology·1999
    Same journal

    Splenectomy during pregnancy: an option in treatment of autoimmune thrombocytopenic purpura.

    British journal of obstetrics and gynaecology·1999
    Same journal

    Third trimester abortion: is compassion enough?

    British journal of obstetrics and gynaecology·1999
    See all related articles

    Practolol can cause sclerosing fibro-peritonitis, a rare condition that may appear months after stopping the drug. This condition can mimic a pelvic mass, presenting a diagnostic challenge for gynecologists.

    Area of Science:

    • Gastroenterology
    • Pharmacology
    • Gynecology

    Background:

    • Practolol is a beta-blocker previously used for cardiovascular conditions.
    • Drug-induced conditions can manifest with diverse and delayed presentations.
    • Sclerosing fibro-peritonitis is a rare but serious intra-abdominal adhesion disorder.

    Observation:

    • A case of sclerosing fibro-peritonitis is presented.
    • The condition occurred in a patient with a history of practolol therapy.
    • Symptoms arose months after discontinuing practolol due to other side effects.

    Findings:

    • Practolol therapy is identified as the cause of sclerosing fibro-peritonitis.
    • The condition can present as a pelvic mass, potentially misleading gynecological diagnosis.

    Related Experiment Videos

  • Delayed onset of symptoms after drug cessation is a key characteristic.

    • Implications:

    • Highlights the importance of considering drug history in unexplained pelvic masses.
    • Underscores the potential for rare, long-term adverse effects of medications.
    • Emphasizes the need for awareness among clinicians regarding practolol-induced complications.